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Abstract
BACKGROUND & AIMS—Interleukin (IL)-8 has an important role in initiating inflammation in
humans, attracting immune cells such as neutrophils through their receptors CXCR1 and CXCR2.
IL-8 has been proposed to contribute to chronic inflammation and cancer. However, mice do not
have the IL-8 gene, so human cancer cell lines and xenograft studies have been used to study the
role of IL-8 in colon and gastric carcinogenesis. We generated mice that carry a bacterial artificial
chromosome that encompasses the entire human IL-8 gene, including its regulatory elements
(IL-8Tg mice).
METHODS—We studied the effects of IL-8 expression in APCmin+/− mice and IL-8Tg mice
given azoxymethane and dextran sodium sulfate (DSS). We also examined the effects of IL-8
expression in gastric cancer in INS-GAS mice that overexpress gastrin and IL-8Tg mice infected
with Helicobacter felis.
RESULTS—In IL-8Tg mice, expression of human IL-8 was controlled by its own regulatory
elements, with virtually no messenger RNA or protein detectable under basal conditions. IL-8 was
strongly up-regulated on systemic or local inflammatory stimulation, increasing mobilization of
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immature CD11b+Gr-1+ myeloid cells (IMCs) with thioglycolate-induced peritonitis, DSS-
induced colitis, and H. felis–induced gastritis. IL-8 was increased in colo-rectal tumors from
patients and IL-8Tg mice compared with nontumor tissues. IL-8Tg mice developed more tumors
than wild-type mice following administration of azoxymethane and DSS. Expression of IL-8
increased tumorigenesis in APCmin+/− mice compared with APC-min+/− mice that lack IL-8; this
was associated with increased numbers of IMCs and angiogenesis in the tumors.
CONCLUSIONS—IL-8 contributes to gastrointestinal carcinogenesis by mobilizing IMCs and
might be a therapeutic target for gastrointestinal cancers.
Keywords
Colon Cancer; Gastric Cancer; Mouse Model; Immune Regulation
Early-stage colorectal cancer has a 5-year survival rate of ~90%; however, survival is
dramatically reduced by local recurrence and metastases.1 In colon cancer, interleukin (IL)-8
is up-regulated in most tumors and has been associated with poor tumor differentiation,
metastasis, and tumor progression.2 In vitro, IL-8 is able to stimulate the proliferation and
migration of colorectal cancer cell lines,2,3 whereas in vivo studies indicate that
neutralization of IL-8 can reduce the invasive potential of colonic tumors.4 Overexpression
of IL-8 has also been observed in gastric cancer, and its expression negatively correlates
with prognosis.5 Thus, a clearer understanding of the role of IL-8 in early carcinogenesis
would help realize the potential of an attractive therapeutic target.
IL-8, also known as CXCL-8, was originally purified from lipopolysaccharide (LPS)-
stimulated human monocyte cultures and subsequently shown to induce neutrophil and T-
lymphocyte chemotaxis, activate neutrophils, and enhance expression of neutrophil adhesion
molecules.6 IL-8 can be produced by virtually all nucleated human cells but is primarily
expressed in nonepithelial cell types.6,7 In inflamed tissues, the primary source of secreted
IL-8 appears to be myeloid cells, where the gene is transcriptionally up-regulated by
activator protein 1 and nuclear factor κB.8 IL-8 is normally undetectable in healthy tissues,
but its expression is strongly up-regulated by proinflammatory cytokines or pathogen-
associated factors through the Toll-like receptors in wounded and/or infected tissues.8,9
Previous studies have proposed that secreted IL-8 rapidly recruits and activates neutrophils
to inflamed sites by binding with high affinity to two G protein–coupled receptors: CXCR1
and CXCR2.10,11 CXCR1 binds IL-8 and the chemokine NAP-2,12,13 whereas CXCR2 is
more promiscuous and binds to several CXC chemokines, including CXCL1 and CXCL8/
IL-8,12 and is postulated to mediate the angiogenic activity and direct tumor proliferative
effects of IL-8.13 Moreover, the implication of CD11b+Gr-1+ immature myeloid cells
(IMCs) in tumorigenesis has recently raised the possibility that IL-8 is critical for mobilizing
IMCs to the cancer niche. CD11b+Gr1+ cells comprise a heterogeneous group that includes
myeloid-derived suppressor cells (MDSCs), which have been suggested to contribute to
progression of tumorigenesis.14,15 However, many cancers express CXCR2, and thus
whether IL-8 stimulates tumor growth directly or indirectly through effects on stromal cells
has not been clarified.
ASFAHA et al. Page 2
Gastroenterology. Author manuscript; available in PMC 2014 April 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Despite the primary source of IL-8 is immune cells, studies of IL-8 have primarily been
limited to human cancer cell lines because rodents lack the IL-8 gene. Thus, the contribution
of stromal or myeloid cell–derived IL-8 in carcinogenesis has not been studied. The
homologue of human IL-8 is completely absent from the genome of rodents, and for many
years it was assumed that the absence of IL-8 in mice was compensated for by the ligands
Cxcl1/KC and Cxcl2, which bind the murine CXCR2 receptor and attract immune cells into
inflamed tissues.16 However, more recently, recombinant IL-8 was shown to play a
nonredundant role in proper neutrophil extravasation in the colon of mice with acute
Shigella-induced colitis.17 In addition, whereas mice were initially believed to lack the
Cxcr1 receptor, the murine Cxcr1 homologue (mCxcr1) has been cloned and shown to be
functionally active.18,19
Previously generated IL-8 transgenic (IL-8Tg) mouse models have used constitutive tissue-
specific or xenobiotic-inducible promoters that have resulted in high constitutive levels of
circulating IL-8 atypical of that normally observed in humans.20,21 Thus, the presence of
high levels of circulating IL-8 in unchallenged animals, and the absence of physiologic
regulation of IL-8 in these earlier models, has limited the conclusions that could be reached
regarding IL-8 function. The IL-8 gene is tightly regulated by several distant upstream and
downstream promoter elements that are located within at least ~75 kilobases of the
surrounding genomic region.22 With this in mind, we developed a physiologically regulated
transgene by using a bacterial artificial chromosome (BAC; 166 kilodaltons) encompassing
the entire human IL-8 gene. Here, we provide experimental data suggesting that this strategy
recapitulates human-like IL-8 expression in appropriate murine tissues in several broadly
used models of systemic and local inflammation. Our data also suggest that IL-8 expression
exacerbates acute inflammation and promotes acceleration of colonic and gastric
carcinogenesis in mice through remodeling of the tumor microenvironment.
Materials and Methods
Isolation and Characterization of a Bacterial Artificial Chromosome
A human bacterial artificial chromosome (hBAC; RPL11-997L11) encompassing the entire
IL-8 gene was purchased through CHORI (Oakland, CA) (Supplementary Figure 2A). To
ascertain proper IL-8 gene splicing in mouse cells, the hBAC plasmid (20 μg) was
transfected into mouse dendritic DC2.4 cells that were subsequently treated with 50 ng/mL
of mouse IL-1β. Polymerase chain reaction (PCR) using IL-8 –specific primers in different
exons confirmed proper splicing of IL-8 (see Supplementary Materials and Methods for
details). Transgenic mice (CBA/C57BL/6) bearing IL-8 hBAC were subsequently generated
in the Transgenic Core Facility of Columbia University. hBAC-specific PCR primers were
used to genotype hBAC-positive transgenic pups. All animal studies were performed in
institutional animal care and use committee–approved facilities at Columbia University.
Analysis of Human Colorectal Cancer
In the present study, colonic tissue biopsy specimens were obtained from patients with
colorectal cancer who had undergone surgical resection at Fox Chase Cancer Center
(Philadelphia, PA). Identifying information of subjects was removed from biopsy
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specimens, and samples were processed for RNA extraction. The experimental protocol was
approved by the institutional review board.
See Supplementary Materials and Methods for detailed information on methods.
Results
IL-8 Expression Is Increased in Colorectal Tumors and Contributes to Enhanced Intestinal
Carcinogenesis in Humans and IL-8Tg Mice
To confirm that IL-8 plays a role in colon cancer in humans, we examined IL-8 expression
in colonic tumors of patients undergoing colorectal cancer resection for stage II or stage III
colon cancer. Using real-time quantitative reverse-transcription PCR, we detected
significantly increased levels of IL-8 messenger RNA (mRNA) in colonic tumors compared
with adjacent normal colonic tissue from the same patients (n = 10) (Figure 1A).
Given that mice lack the IL-8 gene, we used a BAC approach to generate transgenic mice
expressing human IL-8. The RP11-997L11 BAC encompassing the entire IL-8 gene spanned
166 kilobases of DNA from human chromosome 4 (shown in Supplementary Figure 1A) and
was injected into the mouse germline. Germline transmission was achieved in 5 founders,
and each line showed a unique autosomal integration site. For one founder line, the unique
integration site was directly visualized with fluorescent in situ hybridization (Supplementary
Figure 1B). Real-time PCR revealed that 1, 2, and 4 copies of the IL-8 transgene integrated
into the chromosome(s) of 3 founder mice, #18, #176, and #180, respectively (data not
shown). Progeny of the latter 2 lines, containing 2 and 4 transgene copies, respectively, were
used in subsequent experiments.
Unchallenged IL-8Tg mice were indistinguishable in appearance, body weight, behavior,
fertility, and life span from their wild-type (WT) littermates. Complete blood cell counts did
not reveal any significant difference in hematopoietic parameters at baseline (Supplementary
Figure 1C), and histologic examination of the colon and stomach from specific pathogen-
free– housed transgenic mice (up to 18 months) showed no inflammatory changes. At
baseline, IL-8 mRNA and protein in the gastrointestinal tract (or compensatory increase in
MIP-2 or Cxcl1/KC) and circulation were not detectable in transgenic mice. To stimulate
IL-8 expression, acute systemic inflammation was induced by LPS and IL-8 measured
before and 4 hours after administration of LPS. LPS induced serum IL-8 levels (up to 15
nmol/L) in proportion to the number of transgene copies present (Supplementary Figure
1D), whereas unchallenged transgenic mice had levels below the detectable threshold of the
IL-8 enzyme-linked immunosorbent assay (<3 pg/mL).
To examine the contribution of IL-8 to tumorigenesis, colonic tumor number and size were
assessed 20 weeks after administration of azoxymethane (AOM) injection and dextran
sodium sulfate (DSS) (10 days in drinking water) (Figure 1B). IL-8Tg mice had significantly
increased tumors (WT, 1.7 ± 0.2 tumors; IL-8, 5.6 ± 1.8 tumors; P < .05) (Figure 1B and C),
with most of the increased tumor load attributable to larger tumors (>0.5 cm in diameter).
On average, IL-8Tg mice had 3.4 ± 1.5 tumors and WT mice had 0.2 ± 0.2 tumors greater
than 0.5 cm in diameter (P < .01) (Supplementary Figure 2A). Similarly, APCmin+/− mice
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crossed to IL-8Tg mice developed a greater number of small intestinal tumors than APC-
min+/− controls (Figure 1F).
Colonic histology from IL-8Tg mice with acute (7 day) colitis revealed increased
inflammatory cell infiltrate compared with similarly treated WT controls (Figure 3A and B
and Supplementary Figure 2C). A similar trend was observed in IL-8Tg versus WT tumor-
bearing mice at later time points (Figure 1E and Supplementary Figure 2C), although the
difference in histopathologic scores did not reach statistical significance (Supplementary
Figure 2C). Coinciding with enhanced colonic carcinogenesis, human IL-8 (hIL-8) mRNA
was significantly increased in the colon (Figure 1D) and circulating IL-8 levels were
elevated in tumor-bearing mice (Supplementary Figure 2B). Interestingly, increased
carcinogenesis was associated with greater spleen size and increased inflammatory cells in
tumor-bearing IL-8Tg versus WT mice (Supplementary Figure 2D and E). Furthermore, we
observed increased epithelial proliferation as determined by Ki67+ staining in IL-8Tg
compared with WT mice (Supplementary Figure 2F).
IL-8 Enhances Helicobacter- and Gastrin-Dependent Gastric Carcinogenesis
Additionally, we performed gastric carcinogenesis studies in IL-8 and WT mice infected
with Helicobacter felis, a bacterial strain that induces chronic gastritis, dysplasia, and
eventually carcinoma.23 Mice were examined at 6, 12, and 18 months (n = 5 per group)
following H felis inoculation. At 6 and 12 months postinfection, no differences in histologic
scores were observed (data not shown). However, at 12 months, gastric dysplasia was
detected only in IL-8Tg mice, and at 18 months postinfection, pseudopy-loric metaplasia,
foveolar hyperplasia, and dysplasia were significantly increased in the stomach of IL-8Tg
mice (Supplementary Figure 3A and B).
Correspondingly, in uninfected WT and IL-8Tg cohorts (controls) and in H felis–infected
WT mice, serum IL-8 levels remained undetectable during the 18-month period
(Supplementary Figure 3C). However, in H felis–infected IL-8Tg mice, serum IL-8 levels
increased significantly by 6 months postinfection and remained elevated at 12 and 18
months postinfection (Supplementary Figure 3C). Gastric IL-8 mRNA expression was also
elevated at baseline in H felis–infected IL-8Tg mice versus WT controls and remained
elevated over the 6- to 18-month postinfection period.
To investigate the effect of IL-8 in a second model of gastric cancer, we used our
hypergastrinemic INS-GAS mice that develop spontaneous corpus gastric tumors.24 Using
gastric cancer cell lines, it was previously shown that IL-8 is secreted in direct response to
gastrin in vitro.25 Thus, to determine whether IL-8 is a downstream target of gastrin in vivo,
INS-GAS mice were crossed with IL-8Tg mice. Consistent with the H felis model, double
transgenic INS-GAS/IL-8 mice showed accelerated tumor progression and an increased
number of invasive tumors (Supplementary Figure 4A and B) compared with INS-GAS
mice. At 12 months of age, the serum IL-8 level in INS-GAS/IL-8 mice was significantly
increased compared with single IL-8Tg controls (Supplementary Figure 4D). Similarly,
gastric IL-8 mRNA expression in INS-GAS/IL-8 mice was significantly increased compared
with IL-8Tg controls (Supplementary Figure 4D).
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The Predominant Source of IL-8 Is Macrophages and Dendritic Cells
We investigated the cellular source of IL-8 by comparing 3 short-term primary cultures
using thioglycolate-mobilized peritoneal macrophages, bone marrow– derived dendritic
cells, and colonic epithelial cells. IL-8 secreted into the culture medium following treatment
with LPS was then measured by enzyme-linked immunosorbent assay. In the absence of
stimulation, low levels of IL-8 (ranging between 50 pg/mL and 5 ng/mL) were detected
(Supplementary Figure 5A). However, IL-8 was strongly up-regulated by LPS in a time- and
dose-dependent manner (Supplementary Figure 5A), and IL-8 production was much higher
(~8-fold greater) in immune cells (ie, macrophages and dendritic cells) than colonic
epithelial cells (Supplementary Figure 5A). IL-8 secretion from immune cells peaked at 8
hours (Supplementary Figure 5A), whereas epithelial cells displayed a more gradual
response (peak at ~18 to 24 hours) (data not shown). Taken together, these data suggest that
myeloid cells are the primary source of IL-8 during the acute inflammatory response in LPS-
challenged transgenic mice.
IL-8Tg Mice Show Enhanced Mobilization of IMCs in Acute Inflammation
To characterize the effects of hIL-8 on mobilization of immune cells, we performed
fluorescence-activated cell sorting (FACS) analysis of immune cells mobilized upon
recombinant hIL-8 injection (100 ng). IL-8 mobilized a significantly higher number of
CD11b+Gr-1+ IMCs compared with saline (16% vs 8%, respectively) (Figure 2A and C).
The majority of this myeloid population (~96%) expressed the IMC marker CD3126 (Figure
2A), but these cells were clearly heterogeneous as determined by expression of F4/80+,
Ly6C, and/or Ly6G (Figure 2A, B, and D). Indeed, detailed FACS analysis of the immune
cell subsets revealed a significant increase in both Ly6G+Ly6C+ IMCs and Ly6G-Ly6C+
monocytic cells (Figure 2D). As predicted, granulocytic Ly6G+Ly6C− immune cells were
also mobilized to the peripheral blood to a greater extent than in saline controls, although
this increase was not statistically significant.
We further assessed the effects of IL-8 on inflammatory cell mobilization in acute systemic
inflammation induced by LPS and acute peritonitis induced by thioglycolate (TTG) broth.
LPS was effective in mobilizing a greater number of CD11b+Gr-1+ IMCs in IL-8Tg versus
WT control mice (~70% vs ~30%, respectively) (Figure 2E). Once again, these myeloid
cells were predominantly (~90% of IMCs) CD31+ (data not shown) and included subsets
expressing Ly6C and/or Ly6G (Figure 2F). Interestingly, the significant increase in myeloid
subsets in IL-8Tg mice was predominantly due to Ly6G+Ly6C+ IMCs (Figure 2F). A
greater number of Ly6G+Ly6C− granulocytic cells were also mobilized in IL-8Tg mice
versus WT mice treated with LPS, although this did not reach statistical significance (Figure
2F). Microscopic assessment of the various myeloid cell subsets revealed the characteristic
polymorphonuclear morphologic appearance of granulocytic Ly6G+Ly6C+ immune cells,
whereas Ly6G+Ly6C− myeloid cells displayed a ring-shaped nuclear structure characteristic
of more IMCs (Supplementary Figure 6E) as previously described.26
Similarly, 3 hours after thioglycolate challenge, the number of immune cells was
significantly increased in association with elevated IL-8 in the peritoneum of IL-8Tg versus
WT mice (Supplementary Figure 5B and C). Accordingly, myeloperoxidase activity
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(derived primarily from myeloid cells) was ~1.5-fold higher in the peritoneum of TTG-
challenged IL-8Tg versus WT mice (Supplementary Figure 5D). To confirm inflammatory
cell mobilization was due to IL-8, we pretreated IL-8Tg mice with an IL-8 neutralizing
monoclonal antibody or an unrelated mouse monoclonal immunoglobulin G 2a control
antibody before TTG challenge. Pretreatment with IL-8 antibody significantly reduced the
number of inflammatory cells in the peritoneum versus isotype-treated IL-8Tg mice
(Supplementary Figure 5E). Thus, secreted IL-8 has a nonredundant role in myeloid cell
mobilization. Moreover, characterization of these myeloid cells revealed a significantly
greater number of CD11b+Gr-1+ cells in the peritoneum of TTG-treated IL-8Tg versus WT
mice, with the majority of this increase due to Ly6G+Ly6C+ IMCs (Supplementary Figure
5F).
To explore further the mechanism for IL-8 promotion of colonic tumorigenesis, we analyzed
immune cells mobilized in acute DSS-induced colitis in IL-8Tg versus WT mice. Not
surprisingly, IL-8Tg mice with DSS-induced colitis displayed increased IMCs
(characterized by CD11b and Gr-1 cell surface marker expression) within the colon (Figure
3B) and spleen (Figure 3C). A similar trend was observed in the peripheral blood, where we
observed increased CD11b+Gr-1+ cells, although this difference did not reach statistical
significance. Similarly, CD11b+F4/80+ macrophages were significantly increased in the
peripheral blood and spleen of DSS-treated IL-8Tg versus WT mice (Figure 3C). The
increased IMCs and macrophages in IL-8Tg mice correlated with exacerbation of DSS-
induced colitis (ie, increased weight loss) (Figure 3D) and reduced survival (data not shown)
compared with WT mice.
To examine further the direct effects of IL-8 on migration of CD11b+Gr-1+ IMCs, Transwell
migration of FACS-sorted CD11b+Gr-1+ bone marrow– derived IMCs incubated in the
presence or absence of IL-8 was assessed (Figure 3E). As an additional control, LPS was
used to induce the migration of/activate IMCs. IL-8 significantly increased migration of
IMCs when compared with cells incubated in the absence of IL-8 or in the presence of LPS
(5 ng/mL) alone (Figure 3E and Supplementary Figure 6C). Taken together, these
observations suggest that hIL-8 is effective in mobilizing mouse IMCs both in vivo and in
vitro.
IL-8 Mobilizes IMCs and Contributes to Remodeling of the Tumor Microenvironment
IL-8 enhanced mobilization of IMCs and resulted in significantly enlarged spleens in tumor-
bearing IL-8Tg compared with WT mice (Supplementary Figure 2D). As a result, we further
characterized these cells within the spleen, bone marrow, and colon. Tumor-bearing IL-8Tg
mice displayed a significant increase in the number of CD11b+Gr-1+ IMCs within the spleen
and bone marrow (Figure 4A, left panel) and an increase in CD11b+ cells within the colon in
both dysplastic (Figure 4C) and adjacent nondysplastic (Figure 4B) tissues. Further
characterization of splenic myeloid cells of tumor-bearing IL-8Tg mice revealed an increase
not only in Ly6G+ granulocytic cells but in all immature myeloid cell subsets, with the
greatest increase attributable to Ly6C+Ly6G− and Ly6C+Ly6G+ cells, although these
differences were not statistically different (Figure 4A, right panel). Similarly, ~40% of total
splenic cells were CD11b+Gr-1+ in tumor-bearing APCmin+/− mice at 16 weeks of age,
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whereas IL-8 × APCmin+/− mice displayed an even greater number (~70%) of CD11b+Gr-1+
cells (Supplementary Figure 6A). The increased IMCs in IL-8 × APCmin+/− mice were
predominantly Ly6C+ rather than Ly6G+ cells (Supplementary Figure 6B). Recruitment of
IMCs has also previously been shown to lead to accumulation of cancer-associated
fibroblasts and increased tumor angiogenesis.27 In comparing the colonic tumors of our
IL-8Tg versus WT mice, we similarly observed increased staining of the cancer-associated
fibroblast marker α–smooth muscle actin (SMA), macrophage marker F4+/80+, and the
angiogenesis marker endomucin (Figure 4D–F).
Additionally, we compared immune cell types in colonic tumors of IL-8Tg versus WT mice
by microarray analysis of tumors using the gene expression Barcode method28 to determine
the presence or absence of genes characteristic of various immune cell types. We identified
3 genes (Ighm, Tsc22d3, and Cx3cr) expressed in immune cells that were expressed in all 3
IL-8Tg mouse colonic tumors but not in any of the WT control tumors examined. Of these,
however, only Ighm was significantly different in the array experiments (log2FC = 6.13, P =
8 × 10−6, false discovery rate (fdr) = 0.04) and confirmed by PCR (Table 1). According to
the Barcode database, and confirmed by our own reverse-transcription PCR analysis of
splenic immune cells, Ighm was expressed primarily in B cells (as expected) and less
frequently in T cells (Supplementary Figure 7A). Thus, our results suggest that B cells may
have a role in the IL-8 –induced immune response and could also contribute to the
mechanism of IL-8 –mediated cancer progression, although further work is needed to
understand its relevance to tumorigenesis.
IMC-Derived IL-8 Promotes Tumor Growth and Tumor Remodeling
Whereas myeloid cells serve as the primary source of IL-8 (Supplementary Figure 5A),
transformed epithelial cells show increased IL-8 expression (Figure 1A and D), and previous
studies using human cancer cell lines have implicated only tumor-derived IL-8 in
carcinogenesis. To specifically address the contribution of immune cell– derived IL-8 in
tumorigenesis, we performed xenograft studies using CT-26 BALB/c mouse colon cancer
cells that do not express IL-8.
CT-26 colon cancer cells were coinjected subcutaneously into NOD-SCID mice, with or
without bone marrow– derived IMCs (CD11b+Gr-1+) derived from IL-8Tg mice or WT
mice. IMCs from IL-8Tg mice significantly enhanced the growth of xenograft tumors when
compared with CT-26 cells implanted alone or in combination with IMCs from WT mice
(Figure 5A and B). Indeed, IMCs from IL-8Tg mice expressed IL-8 mRNA on stimulation
(ie, with LPS) (Figure 5D and E), and both the CT-26 mouse cancer cells and IMCs
expressed the IL-8 receptors Cxcr1 and Cxcr2 (Figure 5F). Thus, IL-8 receptors on both
IMCs and dysplastic epithelial cells allow for autocrine and paracrine action of IL-8 (Figure
5F and Supplementary Figure 6D).
Interestingly, coimplantation of IL-8 – expressing IMCs led to altered tumor histology, with
increased stromal expansion (Figures 5C, 6A, and 6B) and immunohisto-chemical analysis
of xenograft tumors confirming the presence of significantly increased cancer-associated α-
SMA–positive fibroblasts (Figure 6C), increased epithelial cell (Ki67+) proliferation (Figure
6D), and increased endomucin-positive angiogenesis (Figure 6E). These data clearly
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implicate IL-8 –producing IMCs in remodeling of the tumor environment and promotion of
tumor growth.
Discussion
In this study, we used a BAC encompassing the entire IL-8 gene regulatory elements to
generate IL-8 –expressing transgenic mice that recapitulate human physiologic IL-8
expression. Transgenic mouse models expressing constitutively high levels of hIL-8 have
previously been reported20,21; however, none have exhibited a physiologic pattern of IL-8
expression with strict inducibility by injury or infection. Here, we show that IL-8 BAC
transgenic mice do not exhibit detectable circulating IL-8 at baseline, but following
inflammatory injury show significantly increased levels of IL-8 in diseased tissues and the
circulation. As in humans, the predominant cellular source of IL-8 in these mice was
myeloid, with dramatically lower levels in epithelial cells. Interestingly, our IL-8 BAC
trans-genic mice displayed heightened inflammatory responses to LPS, TTG-induced
peritonitis, DSS-induced colitis, and Helicobacter infection. Importantly, IL-8Tg mice
displayed significant acceleration of inflammation-associated colonic and gastric
carcinogenesis in association with enhanced mobilization of CD11b+Gr1+ IMCs. Taken
together, these data show an important role for stromal-derived IL-8 in the mobilization of
IMCs and initiation of gastrointestinal tumors.
We and others have recently shown that CD11b+ Gr-1+ IMCs play an important role in
influencing the tumor microenvironment and promoting tumor progression.27,29 In cancer,
IMCs have immune suppressive activity that mediates tumor promotion.14,15 In this study,
we report enhanced mobilization of CD11b+Gr-1+ IMCs in inflammation and in tumor-
bearing IL-8 BAC transgenic mice, supporting a role for these cells in the initiation and
progression of gastrointestinal carcinogenesis. Importantly, when implanted with CT-26
colon cancer cells in NOD-SCID mice, IL-8 – expressing IMCs increased tumor growth.
These CD11b+Gr-1+ cells, also labeled MDSCs, negatively regulate immune responses
during cancer15 and are increased 10-fold in the spleen of many mouse tumor models and
increased 10-fold in the blood of patients with various cancers.15 We observed similar
increases in splenic MDSC/IMCs in tumor-bearing IL-8Tg mice, pointing to a possible role
for IL-8 in expansion of MDSCs. The enhanced immune cell mobilization was almost
certainly due to IL-8 because this was observed in 2 independent transgenic lines, and an
IL-8 neutralizing antibody partially inhibited this response. Moreover, IL-8 augmented both
systemic (ie, LPS-induced) and local (ie, TTG-induced peritonitis, DSS-induced colitis)
acute inflammatory responses in rodents to establish a nonredundant role for IL-8 in
inflammation and carcinogenesis.
Although previous studies examining the role of IL-8 in inflammation have focused on its
effects on mobilization of neutrophils, our data suggest that IL-8 exerts its predominant
effect on the expansion and recruitment of CD11b+Gr-1+ IMCs that coexpress the immature
myeloid cell marker CD31 and are morphologically distinct from mature neutrophils. These
cells are phenotypically heterogeneous, expressing the granulocytic marker Ly6G, the
monocytic marker Ly6C, or a combination of the two. Thus, in the presence of IL-8, IMCs
mobilized from the bone marrow early and throughout tumor development influence the
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tumor microenvironment to accelerate tumorigenesis. Moreover, the similarity in immune
cell profile and gene expression pattern in colonic tumors from IL-8Tg versus WT mice is
consistent with enhanced recruitment of IMCs rather than a change in immune cell
phenotype, being more important for enhanced tumor initiation and progression. Akin to the
recently reported effects of epithelial tumor– derived granulocyte-macrophage colony–
stimulating factor in promoting tumor growth via recruitment of IMCs to the tumor, IL-8
similarly promoted tumorigenesis through enhanced mobilization of IMCs.15,30–32
Furthermore, on tumor establishment, epithelial-derived IL-8 promotes tumor progression
through proangiogenic and pro-proliferative effects. This is consistent with previous in vitro
studies using human cancer cells and xenograft tumors showing tumor promotion via IL-8 –
induced angiogenesis and epithelial proliferation.13
Although we cannot exclude a role for epithelial cell–derived IL-8, our data clearly suggest
that inflammatory cell– derived IL-8 plays a key role in the mobilization of CD11b+Gr-1+
IMCs critical in initiation as well as progression of both colonic and gastric carcinogenesis.
Interestingly, the 2 inducers of gastric carcinogenesis (H felis infection and gastrin) used
also up-regulated IL-8 expression and secretion.33 In addition, in our xenograft models of
cancer, IL-8 – expressing IMCs promoted growth of tumor cells lacking IL-8. We
previously defined proinflammatory and tumor-promoting effects of IMCs, independent of
their immune suppressive properties.27,34 Similarly, here we show that enhanced tumor
growth in the presence of IL-8 occurred in association with α-SMA–positive myofibroblast
expansion and increased angio-genesis. Thus, increased α-SMA–positive cells in colonic
tumors of IL-8Tg mice may be due to enhanced mobilization of CD11b+Gr-1+ IMCs or a
direct effect of IL-8 on myofibroblasts.
In summary, we established a physiologic model of IL-8 expression and for the first time
show that endogenous IL-8 enhances acute inflammation by mobilization of predominantly
CD11b+Gr-1+ IMCs and, in turn, accelerates tumorigenesis and remodeling of the tumor
microenvironment. Furthermore, myeloid-derived IL-8 contributes to cancer initiation and
progression, suggesting that pharmacologic inhibition of IL-8 may be a potential strategy for
the prevention and treatment of colon cancer. IL-8 BAC transgenic mice may prove useful
for the development of such targeted therapies in inflammatory disease and cancer.
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AOM azoxymethane
BAC bacterial artificial chromosome
DSS dextran sodium sulfate
FACS fluorescence-activated cell sorting
hBAC human bacterial artificial chromosome
hIL-8 human interleukin-8
IL interleukin
IL-8Tg interleukin-8 transgenic
IMC immature myeloid cell
LPS lipopolysaccharide
MDSC myeloid-derived suppressor cell
PCR polymerase chain reaction
SMA smooth muscle actin
TTG thioglycolate
WT wild-type
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Figure 1.
IL-8 contributes to intestinal carcinogenesis in humans and IL-8Tg mice. (A) IL-8 mRNA
expression in colorectal tumors and adjacent histologically normal tissue from patients with
colorectal cancer. (B) Representative gross images of colonic tumors from WT versus
IL-8Tg mice treated with AOM plus DSS. (C) Colonic tumor number in IL-8Tg versus WT
mice. (D) IL-8 mRNA expression in dysplastic versus nondysplastic colonic epithelium
from WT and IL-8Tg mice. (E) H&E representative images of colonic tumors from WT and
IL-8Tg mice. (F) Small intestinal adenoma number in IL-8 × APCmin+/− transgenic versus
APCmin+/− mice.
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Figure 2.
IL-8 mobilizes CD11b+Gr-1+ IMCs in acute inflammation. (A) Representative FACS plots
of circulating CD11b+Gr-1+ IMCs following recombinant hIL-8 (100 ng) versus saline
intravenous injection in WT C57BL/6 mice. FACS analysis of IMCs expressing the
immature myeloid cell marker CD31+ and macrophage marker F4/80+. (B) Representative
FACS plot showing Ly6C+ and Ly6G+ myeloid cell subsets mobilized into the peripheral
circulation by hIL-8. (C) Quantitative analysis of CD11b+Gr-1+ IMCs and (D) Ly6C+ and
Ly6G+ myeloid subsets in IL-8Tg versus WT mice following intravenous injection of hIL-8
(100 μg). (E) Quantitative analysis of CD11b+Gr-1+ IMCs and (F) Ly6C+ and Ly6G+
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myeloid cell subsets mobilized to the spleen of IL-8Tg versus WT mice following
intraperitoneal LPS (5 mg/kg) injection (***P < .001 vs WT).
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Figure 3.
IL-8 mobilizes IMCs in acute colitis and induces migration of IMCs in vitro. (A) H&E
staining of colonic tissues from DSS-treated (7 day) WT mice versus untreated or DSS-
treated (7 day) IL-8Tg mice. (B) Immuno-staining of CD11b+myeloid cells in the colon of
DSS-treated (7 day) WT versus untreated or DSS-treated (7 day) IL-8Tg mice. (C) FACS
analysis of CD11b+Gr-1+IMCs and F4/80+ macrophages in the peripheral blood, spleen, and
bone marrow of IL-8Tg versus WT mice at baseline and following 7 days of treatment with
DSS (n ≥ 4 per group). (D) Severity of weight loss in IL-8Tg mice versus WT mice with
DSS-induced colitis (*P < .05; **P < .01). (E) Trans-well migration of CD11b+ Gr-1+ IMCs
in the presence or absence of IL-8 (100 ng/mL) or LPS (5 ng/mL); n = 4 per group.
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Figure 4.
IL-8 mobilizes IMCs in cancer and contributes to remodeling of the tumor
microenvironment. (A) Quantitative analysis of splenic CD11b+Gr-1+ IMCs (left panel) and
Ly6C+ and Ly6G+ myeloid cell subsets (right panel) in IL-8Tg versus WT tumor-bearing
mice 20 weeks after treatment with AOM/DSS. Representative immunostaining of CD11b+
myeloid cells in (B) nondysplastic and (C) dysplastic colonic tissues from AOM/DSS-
treated WT mice versus IL-8Tg mice. (D) Representative immunostaining of F4/80+ tumor-
associated macrophages in serial sections of dysplastic colonic tissue from IL-8Tg versus
WT mice. (E) Representative immunostaining of α-SMA–positive cancer-associated
myofibroblasts in colonic tumors from IL-8Tg and WT mice. (F) Representative
immunostaining of endomucin-positive blood vessels in colonic tumors from IL-8Tg and
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WT mice. Quantitative analyses of CD11b, F4/80, α-SMA, and endomucin immunostaining
in colonic tumors are shown in graphical format next to each representative slide. *P < .05,
**P < .01, ***P < .001 versus respective WT control; n ≥ 5 per group.
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Figure 5.
Myeloid cell– derived IL-8 promotes tumor growth. (A) Xenograft tumor weight of CT-26
mouse colonic cancer cells implanted subcutaneously in NOD-SCID mice either alone or
combined with IMCs from WT mice or IL-8Tg mice. (B) Representative gross images and
(C) H&E microscopic images of the xenograft tumors are shown. (D) IL-8 mRNA
expression in IMCs from WT versus IL-8Tg mice cultured in the presence or absence of
LPS (5 ng/mL). (E) IL-8 mRNA expression in Ly6C+ and/or Ly6C+ myeloid subsets
isolated by FACS from the spleen of LPS-treated (5 mg/kg intraperitoneally) IL-8Tg mice.
(F) CXCR1 and CXCR2 mRNA expression in normal (nondysplastic) colonic epithelial
cells or splenic IMCs from WT versus IL-8Tg mice versus CT-26 mouse colonic cancer
cells cultured in the presence or absence of LPS (100 ng/mL). n ≥ 5 per group.
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Figure 6.
IMC-derived IL-8 contributes to remodeling of the tumor microenvironment ex vivo.
Representative immunostaining of (A) CD11b+ myeloid cells and (B ) F4/80+ tumor-
associated macrophages in CT-26 xenograft tumors implanted alone or in combination with
IMCs from WT or IL-8Tg mice. Representative immunostaining of (C) α-SMA–positive
cancer-associated myofibroblasts, (D) Ki67+ proliferating cells, and (E) endomucin-positive
blood vessels in CT-26 xenograft tumors implanted alone or in combination with IMCs from
WT or IL-8Tg mice. Quantitative analyses of CD11b, F4/80, α-SMA, and endomucin
immunostaining are shown in graphical format next to each slide. n ≥ 5 per group.
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Table 1
Genes Identified as Present or Absent in IL-8Tg Versus WT Colonic Tumors Using the Microarray Gene
Expression Barcode Method
Gene Description logFC P value
Ighm Ig heavy constant mu 6.1 8.44 × 10−6
Tsc22d3 TSC22 domain family, member 3 0.9 .011
Cx3cr1 Chemokine (C-X3-C) receptor 1 −2.2 .001
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